The role of TMEM106B in Alzheimer’s disease pathophysiology
Project Overview
Alzheimer’s disease is a common form of memory loss and confusion affecting older adults. Despite many years of study, we still don’t have a cure for this disease. Researchers have found that certain genes might play a role, but we are still trying to understand how these genes actually cause Alzheimer’s. One such gene, called TMEM106B,has caught our attention because of its unique properties.
Our study aims to understand how changes in the TMEM106B gene contribute to Alzheimer’s disease. Specifically,we want to find out if altering this gene’s activity can affect the buildup of harmful substances in the brain, which is a hallmark of Alzheimer’s.
We will use special lab-grown brain cells, derived from human stem cells, to study the TMEM106B gene. By using advanced techniques, we can either increase or decrease the activity of this gene and observe the effects on the brain cells. This approach is different from previous studies because it allows us to directly manipulate the gene in a controlled setting, offering more precise insights.
Understanding how the TMEM106B gene works could lead to new ways of treating or even preventing Alzheimer’s disease. If we find that adjusting this gene’s activity can lessen harmful substances in the brain, we could be one step closer to developing effective treatments for Alzheimer’s.
Our research is particularly important for people who are living with Alzheimer’s or are at risk of developing it. By studying this gene, we are digging deeper into the root causes of Alzheimer’s, which could eventually help us to find new treatments that can improve the quality of life for those affected by this devastating disease.
Principal Investigator
Anthony Flamier , Université de Montréal
Partners and Donors
Alzheimer Society of Canada